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Particulate Matter with 
Genetic Alterations
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In their article, Tarantini et al. (2009) focused 
on the basic question of mutual relationships 
between environmental and genetic factors. 
From a more general point of view, this also 
involves the question concerning the rela-
tive role of “intrinsic toxicity” of xeno  biotics 
and individual susceptibility or host response. 
In particular, data from epidemiologic and 
in vitro studies must cope with pathologic 
evidence for pathologists, as well as cause-and 
effect-relationships for patho  physiologists. In 
between are inferences and extrapolations on 
the basis of plausibility.
Tarantini et al. (2009) showed, for the 
first time in humans, that reactive oxygen 
species (ROS)—which are considered one 
of the main cellular stressors generated 
by PM exposure—may produce genomic 
hypo  methylation and increased expres-
sion and activity of inducible nitric oxide 
synthase (iNOS) not only in vitro, but in 
humans exposed to particulate matter (PM). 
Although this finding is expected, it is a step 
forward, based on DNA adduct generation 
produced by poly  cyclic aromatic hydro-
carbons (PAHs) and other PM compo-
nents, namely transition metals. Alterations 
of DNA methylation of the promoter is a 
common finding in environmental-related 
chronic or cancerous diseases.
Alterations in DNA methylation and 
iNOS methylation, as observed by Tarantini 
et al. (2009) in association with exposure 
to PM < 10 µm in aerodynamic diameter, 
may represent an initial step in reproducing 
decreases in global DNA methylation content 
that are eventually observed in cardio  vascular 
diseases and cancer. 
However, pathologists and patho-
physiologists are required to interpret more 
correctly what this means. Subjects with 
inherited multi  tumoral syndromes have a 
germline mutation, usually a point mutation 
present in all cells of the body, which deter-
mines the occurrence of multiple tumors in 
the same individual. The occurrence of DNA 
adducts or mutations in some cells or tissues 
due to exposure to PAHs or diesel exhaust 
does not necessarily induce clinically evi-
dent outcomes in the future, because each 
individual is endowed with a wide variety of 
natural defenses and repair mechanisms that 
usually overcome every type of DNA damage. 
Therefore, the first inference to avoid is that 
DNA adduct formation or altera  tions in the 
promoter methylation of a gene causes cancer 
in the absence of inherited or acquired predis-
position (i.e., a point germline mutation of a 
tumor suppressor gene or an acquired sporadic 
mutation). In addition, even in patients with 
inherited multi  tumoral syndromes (i.e., in 
subjects with germline mutations of suppres-
sor genes), tumor occurrence (type and sever-
ity) is also greatly influenced by epi  genetic 
factors, environmental stimuli, or even long-
distance catastrophes. We previously dem-
onstrated an increased incidence of papillary 
thyroid carcinoma in three members of the 
same familial adenomatous polyposis (FAP) 
family (i.e., a kindred having a 1061 APC 
gene mutation). This mutation is responsible 
for FAP, in part as a side effect (long-term–
long-distance) after the Chernobyl disaster, 
thus suggesting a wider than expected impact 
of environmental disasters in pre  disposed sub-
jects (Cetta et al. 1997, 2000). 
Analogously, chronic exposure to toxic or 
carcinogenic environmental substances does 
not elicit the same results in all individuals. 
The final clinical outcome (cancer, asthma, 
pulmonary fibrosis, atherosclerosis, or coro-
nary diseases) seems to be less dependent 
on the toxic potency of the pollutant or of 
the exposure dose and more on the individ-
ual susceptibility of the host (Cetta 2009a, 
2009b). This approach should facilitate a 
better understanding of the < 5% incidence 
of mesotheliomas in subjects with the same 
chronic exposure to asbestos, or the absence 
of health effects in husbands with chronic 
occupational exposure to asbestos but the 
occurrence of mesotheliomas in wives with 
minor indirect exposure from their husbands 
(Cetta F, unpublished data).
However, acute and chronic inflamma-
tion is the first pathological step. The final 
clinical outcome (e.g. cancer) does not 
depend on the first DNA adduct formed 
or a genetic mutation produced by xeno-
biotics. A long, auto  maintaining process 
will start, such as in liver cirrhosis, leading 
to cancer or chronic alterations as the final 
result of the inter  actions between host and 
the pathogenic agent. This process is greatly 
influenced by individual susceptibility or 
resistance. In PM-related diseases, a major 
role—in addition to the intrinsic toxicity of 
the xeno  biotic—is played by individual host 
susceptibility and reactivity, similar to what 
occurs in auto  immune or auto  inflammatory 
diseases.
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Environmental Particulate 
Matter and Genetic 
Alterations: Tarantini et al. 
Respond
doi:10.1289/ehp.0900830R
We thank Cetta et al. for the interest they 
express in our recent article (Tarantini et al. 
2009). The basis for our hypothesis that 
foundry workers exposed to air particles 
might have hypo  methylation of DNA repeti-
tive element was existing evidence demon-
strating that inhaled airborne particles induce 
oxidative stress and in vitro studies indi-
cating that oxidative stress might generate 
hypo  methylation throughout the genome. 
We are glad to see that Cetta et al. also find 
such hypothesis well grounded in previous 
existing work. Our investigation showed for 
the first time that airborne particles induce 
hypomethylation in repetitive sequences that 
are widely represented across the human 
genome, and indicated that hypomethylation 
of the inducible nitric oxide synthase (iNOS) 
gene is one potential mechanism contribut-
ing to particle-induced oxidative stress and 
inflammation. In addition, we showed that 
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such processes can be detected in a DNA 
source, such as peripheral blood leukocytes, 
which is easily obtainable from human sub-
jects. Our findings might be extended to 
ambient air pollution exposures, as suggested 
by our related investigations demonstrating 
repetitive element hypomethylation, as well 
as other gene-specific modifications, in blood 
DNA from individuals exposed to airborne 
benzene (Bollati et al. 2007) or to ambient 
particulate matter (Baccarelli et al. 2009).
In their letter, Cetta et al. rightly empha-
size the possible roles of personal genetic fea-
tures in determining which individuals will 
develop adverse health outcomes in response 
to air particle exposure. This is also confirmed 
by several other investigations that evaluated 
different health-related end points, includ-
ing our previous work demonstrating genetic 
poly  morphisms in pathways related to oxida-
tive stress responses (Chahine et al. 2007) and 
our results on methyl nutrient metabolism 
(Baccarelli et al. 2008), both of which aug-
ment the negative effects of ambient particu-
late matter on cardiac autonomic function. 
In comparison with genetic variations, DNA 
methylation and other epigenetic modifica-
tions are of particular interest with respect to 
air particle effects, because—as demonstrated 
by animal models of environmental epi-
genetic toxicity —they are reversible and may 
be restored to their original state by dietary 
or pharmacologic interventions (Baccarelli 
and Bollati 2009; Dolinoy and Jirtle 2008; 
Jirtle and Skinner 2007).
We agree that the investigation of mecha-
nisms closer to the final health outcomes in 
the chain of events started and/or maintained 
by air pollution exposures is as important as 
investigating early events. Studies tackling 
air pollution effects from different angles are 
needed to link together early events with the 
diseases of concern. As early events may be 
more susceptible to interventions aimed at 
reversing them or slowing their progression, 
we hope that our contribution to identify 
novel modifiable mechanisms induced by 
air particle exposures can help reach the goal 
recently set forth for environmental scien-
tists by the newly appointed director of the 
National Institute of Environmental Health 
Sciences “to prevent or stop the progression of 
complex health problems” (Birnbaum 2009).
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Bisphenol, npcRNAs and 
Utero-Ovarian Feed-Back 
Control of Breast Cancer 
Chemosensitivity 
doi:10.1289/ehp.0900983
In the February 2009 issue of Environmental 
Health Perspectives, La Pensee et al. (2009)
postulated that bisphenol A (BPA), at 
nanomolecular doses, confers chemo  resistance 
in estrogen receptor (ER)-α–positive and 
–negative breast cancer cells. Certainly, drug 
resistance is well-known to be an important 
complication in a variety of cancer chemo-
therapy options. Several molecular mecha-
nisms have been suggested to explain the onset 
of drug resistance. Determining the exact 
mecha  nism in a particular case is challenging 
both at the clinical and pre  clinical research 
levels because the genome-wide and proteomic 
approaches to mechanistic studies are still at a 
developing stage (Zhang and Liu 2007). 
With regard to cisplatin, doxorubicin, and 
vinblastine cytotoxicity, there are proposed 
mechanisms of cyto  toxicity in breast cancer 
cells and cell line  s other than ER or receptor-
mediated molecular signals. These mechanisms 
involve not only apoptosis pathways but also 
other regulatory, functional, and structural 
mechanisms of phenotypic expression in breast 
cancer models that could interfere with andro-
gen receptor-mediated transcriptional activi-
ties (Aube et al. 2008). In addition, after the 
invention of micro  array systems, more focus 
has been placed on the large number of human 
transcripts that have been described but do 
not code for proteins, such as non  protein cod-
ing RNAs (Mallardo et al. 2008). These may 
include sub  fractions of small (microRNAs, 
small nucleolar RNAs) and long RNAs (anti-
sense RNA, double-stranded RNA, and long 
RNA species) that function as regulators of 
other mRNAs at the transcriptional and post-
transcriptional levels and control protein ubiq-
uitination and degradation, with possible other 
roles yet to be elucidated. Various species of 
nonprotein-coding RNAs (npcRNAs) have 
been found to be differentially expressed in 
diverse types of cancer, including breast cancer 
subtypes (Mallardo et al. 2008). Because BPA 
is a highly reactive chemical, it would not be 
surprising if it interacts with some of these npc 
RNAs that could mediate ER response. 
Recent reports from other laboratories 
have tended to support a role of npcRNAs 
in BPA-mediated mechanisms involved in 
breast cancer and a possible physio  chemical 
inter  action of BPA with estrogen and non-
estrogen-mediated chemosensitivity-inducing 
pathway elements. For example, Hong et al. 
(2006) used expression micro  array technology 
to predict hormone-responsive activities in 
response to estrogen and endocrine disruptors. 
According to these authors, the expression 
levels of only 555 genes (7.42%) among the 
7,636 genes spotted on micro  array chips were 
enhanced by > 2-fold after treatment with 
estradiol (E2), suggesting that direct or rapid 
response to E2 is widespread at the mRNA lev-
els in these genes. Hong et al. (2006) observed 
that elevated expression levels of the genes 
(over 2-fold) were induced by BPA (8.26%) 
in the uterus of immature rats. Examples of A 342  v o l u m e  117 | n u m b e r  8 | August 2009  •  Environmental Health Perspectives
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differentially expressed representative genes 
include calbindin-D9k (vitamin D-dependent 
calcium-binding protein), oxytocin, adipocyte 
complement related protein (30 kDa), lactate 
dehydrogenase A, and calcium-binding pro-
tein A6 (calcyclin). The mRNA levels of these 
genes were also increased in various phases of 
the menstrual cycle. This study in rats (Hong 
et al. 2006) supports the possibility of dis-
tinct effects of endogenous E2 and environ-
mental endocrine-disrupting chemicals in the 
uterus of women. Involvement of these gene 
transcripts, which are present in breast, uter-
ine, and ovarian tissues, in the environment–
endocrine inter  action suggests the possibility 
of a utero-ovarian feedback control of breast 
cancer chemo  sensitivity effected by npcRNAs.
Sladek and Somponpun (2008) studied 
the effect of vasopressin (VP) on the repro-
ductive cycles of humans; their results suggest 
the involvement of multiple types of ERs in 
the VP-mediated G-protein coupled response 
(Hong et al. 2006). VP, acting through fluid-
electrolyte mechanisms, may have a role in 
the mecha  nism of breast cancer initiation and 
progression, which may be prone to regulatory 
impacts through npcRNAs involved in the 
replication of dys  regulating pathways of the 
mammary epithelium. 
These observations suggest that there may 
be a utero-ovarian feedback control mediated 
by ERs on the uterus that cross-talk with vaso-
neural pathways; the feedback control may 
mediate estrogen involved in chemo  responsive 
pathways of breast cancer. Furthermore, these 
pathways may be regulated by non  coding 
npcRNAs whose functions may be physio-
chemically modified by environmental toxi-
cants such as BPA and other related chemials. 
Since the forum titled “Bisphenol A: An 
Expert Panel Examination of the Relevance 
of Ecological, in Vitro and Laboratory 
Animal Studies for Assessing Risks to Human 
Health” in Chapel Hill, North Carolina, on 
28–30 November 2006 (Keri et al. 2007), 
there has been no meeting convened to discuss 
environmental endocrine disruptors, particu-
larly as it relates to BPA and related chemicals. 
I hope that a future review panel will assess the 
literature on both animals and humans and 
evaluate the role of BPA in carcino  genesis. 
Such an assessment should also include recom-
mendations for future areas of research. 
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Editor’s note: In accordance with journal 
policy, LaPensee et al. were asked whether they 
wanted to respond to this letter, but they chose 
not to do so.
Er r a t a
In the June Science Selection article “Prenatal Preview: Early Bisphenol A Exposure May 
Spawn Late-Life Reproductive Problems” [Environ Health Perspect 117:A256 (2009)], 
diethylstilbestrol is incorrectly identified as an antinausea drug. This drug was actually 
used to prevent miscarriage. EHP regrets the error.
In the “Discussion” (paragraph 14, p. 701) of the article by Guidotti et al. [Environ 
Health Perspect 115:695–701 (2007)], the first two sentences (“There appears to have 
been no identifiable public health impact from the elevation of lead in drinking water 
in Washington, DC, in 2003 and 2004. This may reflect effective measures to protect 
the residents, as 153 reported compliance with recommendations to filter their drinking 
water.”) should have been replaced with the following sentence: “Measures to protect 
residents from exposure to lead in drinking water may have prevented more frequent 
elevations in blood lead.” In addition, on page 695 in the right-hand column, line 4, the 
year 2002 should be given as 2000. The authors apologize for these errors.
In Figure 6C of Moors et al. [Environ 
Health Perspect 117:1131–1138 (2009)], 
the symbols for control and 1 µm STS 
were not correct. The corrected figure is 
presented here. EHP regrets the error.
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